| Authors: |
Aldea M; Department of Medical Oncology, Thoracic and Precision Medicine Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Electronic address: mihaela.aldea@gustaveroussy.fr., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Arcila M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Hatton M; Department of Clinical Oncology, Weston Park Hospital, Sheffield, United Kingdom., Sholl L; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Rolfo C; Department of Medical Oncology, Early Clinical Trials, The Arthur G. James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio., Tagliamento M; Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genova, Italy., Radonic T; Department of Pathology, Amsterdam University Medical Center, Free University Amsterdam, Amsterdam, The Netherlands., Schalper KA; Department of Pathology and Medicine, Yale School of Medicine, New Haven, Connecticut., Subbiah V; Department of Early-Phase Drug Development, Sarah Cannon Research Institute, Nashville, Tennessee., Malapelle U; Department of Public Health, University of Naples Federico II, Naples, Italy., Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota., Manochakian R; Division of Hematology/Oncology, Mayo Clinic, Florida, Florida., Tsao MS; Department of Pathology, University Health Network and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Linardou H; Oncology Department and Clinical Trials Center, Metropolitan Hospital, Athens, Greece., Hui R; Centre of Cancer Medicine, HKU Med, University of Hong Kong, China; University of Sydney, Australia., Novello S; University of Torino, Department of Oncology, San Luigi Hospital, Orbassano, Italy., Greystoke A; Institute of Clinical and Translational Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom., Saqi A; Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York., Lantuejoul S; Department of Molecular Pathology, Centre Léon Bérard, CRCL INSERM U1052-CNRS5286, Université Grenoble Alpes, La Tronche, France., Hwang DM; Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada., Nevins K; International Association for the Study of Lung Cancer, Denver, Colorado., Wynes M; International Association for the Study of Lung Cancer, Denver, Colorado., Waqar S; Division of Oncology, Department of Medicine, Washington University in St. Louis, St. Louis, Missouri., Han Y; Department of Pathology, Shanghai Chest Hospital, Jiaotong University, Shanghai, People's Republic of China., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Chang WC; Department of Pathology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan., Hayashi T; Department of Human Pathology, Juntendo University Faculty of Medicine, Tokyo, Japan., Kim TJ; Department of Hospital Pathology, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Hofman P; IHU RespirERA, Hôpital Pasteur, Université Côte d'Azur, Nice, France., Tavora F; Argos Laboratory, Federal University of Ceara, Fortaleza, Brazil., Hirsch FR; Center for Thoracic Oncology, The Tisch Cancer Institute, Icahn School of Medicine, Mount Sinai Health System, New York, New York., Denninghoff V; Molecular-Clinical Laboratory, University of Buenos Aires-National Council for Scientific and Technical Research (CONICET), Buenos Aires, Argentina., Leighl NB; Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, IHPME, Dalla Lana School of Public Health, Toronto, Canada., Drilon A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Cooper WA; Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, NSW, Australia., Dacic S; Department of Pathology, Yale School of Medicine, New Haven, Connecticut., Mohindra P; Department of Radiation Oncology, University Hospitals, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio., Pavlakis N; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia; The Thoracic Oncology Group of Australasia, Thornbury, Victoria, Australia., Lopez-Rios F; Pathology Department, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Research Institute Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain. |
